» Articles » PMID: 32984420

Treatment of Severe Stable COPD: the Multidimensional Approach of Treatable Traits

Overview
Journal ERJ Open Res
Specialty Pulmonary Medicine
Date 2020 Sep 28
PMID 32984420
Citations 20
Authors
Affiliations
Soon will be listed here.
Abstract

Now that additional treatment options for severe chronic obstructive pulmonary disease (COPD) have emerged in recent years, patients with severe COPD should not be left in the rather hopeless situation of "there is nothing to improve" any more. Inertia or fatalism is a disservice to our patients. Ranging from advanced care planning to quite intense and demanding therapies such as multidisciplinary pulmonary rehabilitation, (endoscopic) lung volume reduction, chronic noninvasive ventilation and lung transplantation, caregivers should try to provide a personalised treatment for every severe COPD patient. In this review, we aim to describe the multidimensional approach to these patients at our centre along the lines of treatable traits leading to specific additional treatment modalities on top of standard care.

Citing Articles

Patient-centered assessment of treatment for alpha-1 antitrypsin deficiency: literature review to identify concepts and measures for people with alpha1-antitrypsin deficiency.

Secinti E, Schantz K, Delbecque L, Krege J, Mangrum R, Curtis S Orphanet J Rare Dis. 2025; 20(1):83.

PMID: 39987184 PMC: 11846308. DOI: 10.1186/s13023-025-03592-9.


Widening the selection criteria for lung volume reduction surgery.

Vandervelde C, Everaerts S, Weder W, Dooms C, Slebos D, Janssens W Eur Respir J. 2024; 65(1.

PMID: 39715645 PMC: 11736308. DOI: 10.1183/13993003.00829-2024.


Comorbidities reduce survival and quality of life in COPD with severe lung hyperinflation.

Ter Haar E, Slebos D, Klooster K, Pouwels S, Hartman J ERJ Open Res. 2024; 10(6).

PMID: 39559450 PMC: 11571074. DOI: 10.1183/23120541.00268-2024.


Interventional pulmonology for chronic inflammatory airway diseases.

Yang H, Chen S, Sun J, Herth F Chin Med J Pulm Crit Care Med. 2024; 2(3):171-181.

PMID: 39403413 PMC: 11471127. DOI: 10.1016/j.pccm.2024.08.001.


Assessment of hyperinflation: comparison of Global Lung Function Initiative and European Community for Steel and Coal lung volume reference equations.

Roodenburg S, van Dijk M, Augustijn S, Klooster K, Slebos D, Hartman J ERJ Open Res. 2024; 10(3).

PMID: 39371297 PMC: 11163279. DOI: 10.1183/23120541.00900-2023.


References
1.
Hawkins P, Johnson L, Nikoletou D, Sherwood R, Polkey M, Moxham J . Proportional assist ventilation as an aid to exercise training in severe chronic obstructive pulmonary disease. Thorax. 2002; 57(10):853-9. PMC: 1746205. DOI: 10.1136/thorax.57.10.853. View

2.
Slebos D, Hartman J, Klooster K, Blaas S, Deslee G, Gesierich W . Bronchoscopic Coil Treatment for Patients with Severe Emphysema: A Meta-Analysis. Respiration. 2015; 90(2):136-45. DOI: 10.1159/000431384. View

3.
Nelson D, Teckman J, Di Bisceglie A, Brenner D . Diagnosis and management of patients with α1-antitrypsin (A1AT) deficiency. Clin Gastroenterol Hepatol. 2011; 10(6):575-80. PMC: 3360829. DOI: 10.1016/j.cgh.2011.12.028. View

4.
Lacasse Y, Bernard S, Series F, Nguyen V, Bourbeau J, Aaron S . Multi-center, randomized, placebo-controlled trial of nocturnal oxygen therapy in chronic obstructive pulmonary disease: a study protocol for the INOX trial. BMC Pulm Med. 2017; 17(1):8. PMC: 5223547. DOI: 10.1186/s12890-016-0343-9. View

5.
Elshof J, Duiverman M . Letter to the editor: "Nasal high-flow versus non-invasive ventilation in patients with chronic hypercapnic COPD" [Letter]. Int J Chron Obstruct Pulmon Dis. 2019; 14:2117-2118. PMC: 6735658. DOI: 10.2147/COPD.S226697. View